BioSpace News Archive

The global anesthesia laryngeal masks market is expected to post a CAGR of over 6% during the period 2018-2022, according to the latest market research report by Technavio.

DUSA Pharmaceuticals, Inc. announced that DUSA has been granted preliminary injunctive relief by a federal district court prohibiting defendants Biofrontera Inc., Biofrontera Bioscience GmbH, Biofrontera Pharma GmbH, and Biofrontera AG (together known as “Biofrontera”) from using DUSA’s confidential and proprietary trade secret information.

Teammates Deliver Clinical Excellence, Improved Patient Care, Innovation, Robust Partnerships, Community Leadership

Generational Equity is pleased to announce the formation of a partnership with its client, GodwinGroup and Local Marketing Solutions Group Inc. (LMSG).

- KPI-121 0.25% expected to be the first product indicated for the temporary relief of signs and symptoms of dry eye disease, if approved -

Pioneering predictive medical image diagnosis platform, the AIHub, has the ability to detect and monitor more than 30 medical conditions from 14 regions of the body with pinpoint accuracy.

Halozyme Therapeutics, Inc. will be presenting at the 37th Annual J.P. Morgan Healthcare Conference in San Francisco on Wednesday, January 9 at 10:30 a.m. PT / 1:30 p.m. ET. Dr. Helen Torley, president and chief executive officer, will provide a corporate overview.

Learn for Life Foundation (LFL) (www.learnforlifefoundation.org) is a registered US non-profit organization co-founded by Matthew and Thomas Thekkethala (https://thomasthekkethala.com/) as the primary initiative of the Thekkethala Family Charitable Trust.

Israeli Knesset approves bill allowing export of medical cannabis

The Michael J. Fox Foundation for Parkinson’s Research (MJFF) announces the first regulatory approval of a Parkinson’s treatment funded by the Foundation